ArticleJournal of racial and ethnic health disparities2026
Persistent Racial and Ethnic Disparities in Untreated Adolescent Depression in the United States, 2021-2024.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdolescents with depression continue to face substantial barriers to treatment, which may be unevenly distributed across racial and ethnic groups. We examined recent trends in adolescent major depressive episode (MDE) and disparities in untreated MDE in the United States.
methodsWe analyzed 2021-2024 National Survey on Drug Use and Health public-use data for adolescents aged 12-17 years. Outcomes were past-year MDE, depression-related treatment receipt, untreated MDE, and untreated MDE with severe role impairment. Survey-weighted logistic regression accounted for the complex survey design and adjusted for sociodemographic, clinical, substance-use, insurance, and county-type characteristics. Adjusted probabilities and absolute differences versus non-Hispanic White adolescents were estimated using marginal standardization.
resultsAmong 43,828 adolescents, weighted past-year MDE prevalence declined from 20.5% in 2021 to 14.8% in 2024. Among adolescents with MDE, treatment receipt increased from 41.8% to 52.2%, while untreated MDE decreased from 58.2% to 47.8%. In the fully adjusted model (n = 8,066), adjusted untreated probabilities were higher among non-Hispanic Black (61.1%), American Indian or Alaska Native (63.6%), Asian (59.8%), multiracial (59.2%), and Hispanic adolescents (57.7%) than among non-Hispanic White adolescents (46.3%), corresponding to absolute differences of 11.4-17.3% points. Uninsured adolescents and those living in nonmetropolitan counties also had higher odds of untreated MDE.
conclusionsAdolescent MDE declined and treatment receipt improved, but substantial inequities in treatment connection remained. Surveillance should track equity-focused treatment metrics alongside symptom prevalence.
Indexed as
Identifiers
42803904What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.